Clinical Trials Logo

Critical Illness clinical trials

View clinical trials related to Critical Illness.

Filter by:

NCT ID: NCT02895659 Completed - Critical Illness Clinical Trials

Fluid Management in Patients Undergoing Cardiac Surgery

Hemacetat
Start date: December 1, 2016
Phase: Phase 4
Study type: Interventional

Background: Currently used crystalloid solutes have a variable composition and may therefore influence acid-base status, intra- and extracellular water content and plasma electrolyte compositions and have a major impact on organ function and outcome. Despite continuing evaluation no superiority of one particular type of fluid has been reached so far. To the best of the investigators' knowledge no study in humans has ever assessed whether the type of crystalloid fluid given for fluid resuscitation in patients undergoing cardiac surgery has an impact on hemodynamic stability and cardiac function so far. Nonetheless in the animal model it was shown that the choice of crystalloid fluid may greatly influence cardiac performance Primary Aim: In this study the investigators want to clarify whether a balanced type acetate-buffered fluid solution in patients undergoing cardiac surgery is associated with better hemodynamic stability and cardiac function than a lactate-buffered crystalloid solute.

NCT ID: NCT02894164 Completed - Clinical trials for Chronic Kidney Disease

Evaluating the Role of Cystatin C and Creatinine as Markers of Renal Recovery in Critically Ill Patients After Acute Kidney Injury.

Start date: January 2008
Phase: N/A
Study type: Observational [Patient Registry]

This is a cohort study in which patients who survive Acute Kidney Injury (AKI) during intensive care unit (ICU) admission are recalled at 3-6 months and renal function tests are performed. The purpose of the study is describe renal function in AKI survivors at follow-up. Additional aims are to determine how well admission values of renal function markers perform as predictors of renal function at follow-up and whether estimates of renal function at follow-up differ depending on which renal function marker is used.

NCT ID: NCT02889146 Completed - Critical Illness Clinical Trials

Progressive Mobility Program and Technology to Improve the Level of Physical Activity and Functionality of ICU Patients

Start date: February 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to verify if a protocol of early and progressive mobility which includes the use of technology is able to increase the level of physical activity and improve functionality and respiratory and muscular function of Intensive Care Unit patients compared with conventional Physical Therapy.

NCT ID: NCT02888860 Completed - Critical Illness Clinical Trials

Innate Immunity Gene Polymorphisms and Yeast Colonization

Candigene
Start date: January 3, 2013
Phase:
Study type: Observational [Patient Registry]

It is proposed to carry out the study in three medical or surgical intensive care units (ICU) in the CHRU, Lille, and the CHU, Besançon. In all patients admitted to these ICU (see Figure 2), a corrected index of colonisation (CIC) will be determined and blood samples will be taken for genotyping of the lectins MBL, Dectin-1 and Galectin-3 and for serology. Over the duration of hospitalisation (on average 28 days) and weekly, fungal colonisation will be assessed in all patients (according to the CIC), and antibodies to yeast glycans will be determined by a simultaneous multiparametric analysis involving several families of natural or synthetic antigens, and the detection of circulating antigens (mannan and β-1,3 glucan).

NCT ID: NCT02881957 Completed - Stroke Clinical Trials

Hypovitaminosis D in Neurocritical Patients

Start date: October 10, 2016
Phase: Phase 2/Phase 3
Study type: Interventional

Vitamin D has been shown to impact prognosis in a variety of retrospective and randomized clinical trials within an intensive care unit (ICU) environment. Despite these findings, there have been no studies examining the impact of hypovitaminosis D in specialized neurocritical care units (NCCU). Given the often significant differences in the management of patients in NCCU and more generalized intensive care units there is a need for further inquiries into the impact of low vitamin D levels in this specific environment. This study proposes a randomized, double-blinded, placebo-controlled, single center evaluation of vitamin D supplementation in the emergent NCCU patient population. The primary outcome will involve length-of-stay for emergent neurocritical care patients. Various secondary outcomes, including in-hospital mortality, ICU length-of-stay, Glasgow Outcome Score on discharge, complications and quality-of-life metrics. Patients will be followed for 6 months post-discharge.

NCT ID: NCT02881801 Completed - Critical Illness Clinical Trials

Patterns of Physical Activity and Sedentary Time in Survivors of a Critical Illness During a Hospital Admission

Start date: March 2015
Phase: N/A
Study type: Observational

This study aims to describe the pattern of active and sedentary time in survivors of a critical illness, at three time points during their hospital admission (awakening in the ICU after ≥ 5 days of mechanical ventilation, discharge to ward and discharge from hospital). The specific research objectives are to 1. Determine the duration of active and sedentary parameters including time and bouts in 24 hour periods 2. Examine changes in the active and sedentary parameters including time and bouts between time points of awakening and both ICU and hospital discharge. 3. Conduct a preliminary examination of relationships between activity and sedentary behaviour metrics with measures of muscle strength, physical function and hospital length of stay.

NCT ID: NCT02877810 Completed - Critical Illness Clinical Trials

Evidence-Based Tele-Emergency Network Grant Program

Start date: November 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the impact of an existing tele-emergency care network on quality of care, appropriateness of care utilization, patient safety (medication errors), and cost effectiveness compared to telephone consultations from a healthcare system prospective.

NCT ID: NCT02875873 Completed - Critical Illness Clinical Trials

Balanced Solution Versus Saline in Intensive Care Study

BaSICS
Start date: May 27, 2017
Phase: Phase 3
Study type: Interventional

A 2x2 factorial randomized study to evaluate the effect of a balanced crystalloid solution compared with 0.9% saline, and of rapid vs. slow infusion on clinical outcomes of critically ill patients

NCT ID: NCT02864017 Completed - Intubation Clinical Trials

Immuno Nutrition by L-citrulline for Critically Ill Patients

Immunocitre
Start date: September 2016
Phase: N/A
Study type: Interventional

The main objective of this study is to demonstrate that the only administration of L-citrulline, can improve immune functions in critically ill patients at high risk of nosocomial infection.

NCT ID: NCT02860572 Completed - Sepsis Clinical Trials

Non-interventional Follow-up Versus Fluid Bolus in RESPONSE to Oliguria in the Critically Ill

RESPONSE
Start date: January 10, 2017
Phase: N/A
Study type: Interventional

Background: After hypotension, oliguria (urine output less than 0.5 mL/kg/h) was the most common trigger to administer fluid bolus in a multinational practice survey in intensive care. The effect of fluid bolus on cardiovascular variables can be very short-lived among patients in shock suggesting that fluid boluses in the optimization phase are unlikely to improve patient-centered outcomes. Moreover, a growing body of evidence suggests a poor renal response to fluid bolus. Objective: To investigate, whether fluid bolus - as a standard of care - improves urine output in oliguric patients compared to a non-interventional follow-up approach without fluid bolus. Design: Investigator-initiated, open, randomized, controlled study Interventions: 1. Intervention group - follow-up without intervention 2. Control group - fluid bolus (500mL of balanced crystalloid over 30 minutes) Randomization: 1:1 stratified according to the site, presence of acute kidney injury, and sepsis Trial size: 130 patients randomized in 2 ICUs